v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Net income $ 36,090 $ 5,397
Adjustments to reconcile net income to net cash provided by operating activities:    
Release of valuation allowance on deferred tax assets (6,397) 0
Indefinite-lived intangible asset impairment 0 25,866
Investment impairment 0 11,000
Deferred taxes 4,930 10,221
Depreciation of fixed assets and amortization of intangible assets 61,897 69,681
Amortization of cloud computing arrangements, debt issuance costs and debt discount 2,629 2,717
Loss on early extinguishment of debt 0 983
Gain on divestiture (6,617) 0
Stock-based compensation 40,320 44,003
Changes in contingent consideration (15,044) (2,407)
Net accretion of discount on available-for-sale investments (1,311) (4,253)
Other net gains 0 (5,887)
Changes in operating assets and liabilities:    
Accounts receivable, net (2,325) (1,943)
Inventories, net 13,340 (32,384)
Prepaid expenses and other assets (10,433) (9,954)
Accounts payable 697 (2,669)
Accrued expenses 11,920 (7,145)
Other liabilities 3,514 5,079
Net cash provided by operating activities 133,210 108,305
Investing activities:    
Acquisition of GQ Bio Therapeutics GmbH (net of cash acquired) (6,335) (16,702)
Proceeds from iovera®° divestiture 73,560 0
Purchases of fixed assets (7,685) (15,115)
Purchases of available-for-sale investments (31,078) (113,450)
Sales of available-for-sale investments 63,550 226,665
Purchase of convertible notes receivable investment 0 (1,250)
Net cash provided by investing activities 92,012 80,148
Financing activities:    
Proceeds from exercises of stock options 834 12
Proceeds from shares issued under employee stock purchase plan 1,722 1,569
Payment of employee withholding taxes on restricted stock unit vests (7,993) (5,474)
Purchase of treasury stock, inclusive of broker fees (50,045) (100,080)
Excise taxes paid on treasury stock repurchases (1,336) 0
Proceeds from Revolving Credit Facility 0 101,000
Repayment of 2025 convertible senior notes 0 (202,487)
Repayment of Term loan A facility 0 (105,312)
Repayment of Revolving Credit Facility (80,000) (5,000)
Payment of debt issuance and financing costs 0 (2,203)
Net cash used in financing activities (136,818) (317,975)
Effect of exchange rate changes on cash and cash equivalents 8 337
Net increase (decrease) in cash and cash equivalents 88,412 (129,185)
Cash and cash equivalents, beginning of period 158,545 276,774
Cash and cash equivalents, end of period 246,957 147,589
Supplemental cash flow information:    
Cash paid for interest 7,010 10,390
Net cash paid for income taxes 1,213 8,944
Non-cash investing and financing activities:    
Fixed assets included in accounts payable and accrued liabilities 3,913 1,116
Excise tax on treasury stock repurchases included in accrued liabilities $ 403 $ 341